CRBP

Corbus Pharmaceuticals Holdings, Inc. CRBP

CRBP
Corbus Pharmaceuticals Holdings, Inc. CDXS
Codexis, Inc. TARA
Protara Therapeutics, Inc. OABI
OmniAb, Inc. PYXS
Pyxis Oncology, Inc. IVVD
Invivyd, Inc. GNFT
Genfit S.A. SGMO
Sangamo Therapeutics, Inc. GNLX
Genelux Corporation OBIO
Orchestra BioMed Holdings, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CRBP CDXS TARA OABI PYXS IVVD GNFT SGMO GNLX OBIO
6M 108.91 % 19.25 % 18.06 % -7.39 % 226.42 % 243.13 % 18.13 % -19.53 % 171.53 % 42.45 %
YTD 40.20 % -46.10 % -8.60 % -53.43 % 104.73 % 364.58 % 12.27 % -43.96 % 224.48 % -26.39 %
1Y 3.49 % -7.39 % 125.66 % -56.53 % -5.46 % 128.93 % -21.82 % -57.78 % 206.67 % -30.04 %
3Y 361.20 % -51.96 % 57.89 % -81.77 % 93.30 % -41.93 % 2.87 % -85.34 % 27.15 % -60.20 %
5Y -41.63 % -80.72 % -74.93 % -83.30 % -73.79 % -89.32 % -3.80 % -94.34 % 27.15 % -63.84 %
10Y -66.71 % -16.82 % -99.11 % -83.30 % -73.79 % -89.32 % -80.60 % -90.70 % 27.15 % -65.26 %
From the beginning -81.24 % -79.68 % -98.73 % -83.30 % -73.79 % -89.32 % -80.60 % -95.80 % 27.15 % -65.26 %

Dividend